Welcome!
ALERT ATTENTION ⚠️
On Saturday April 20th, 2024 at 8:00 AM (UTC), emergency site maintenance has been scheduled for iLab Primary U.S. Details and updates can be found on the Agilent Status Page. For additional information, please contact the Agilent iLab Support by clicking on 'Help' at the top of your account page or by emailing ilab-support@agilent.com.
The Genome Editing Core (GEC) provides Joslin Diabetes Research Center (DCR) investigators with resources to manipulate the genome of laboratory mice with the aim of studying the genetics underlying diabetes and its complications.
The GEC maintains a facility for the generation of transgenic mouse models to aid in studying the genetic mechanisms underlying diabetes in vivo. The mouse modeling facility uses CRISPR/Cas9 or lentiviral RNAi constructs to introduce genome modifications to a variety of mouse lines in order to establish new models of the disease within a living mammalian system.
For CRISPR Screening services please click here
*Please note, external pricing for this core is currenltly in the process of being worked on.
If any of your research has been supported in full or in part by a Joslin Diabetes Center DRC Core, please acknowledge the NIH/NIDDK grant as follows: "Supported by DRC, Grant No. P30 DK036836."
| Stephan Kissler, PhD | Core Director | Stephan.Kissler@joslin.harvard.edu | |
| Taylor Roberts | Sr. Research Assistant | Taylor.Roberts@joslin.harvard.edu |
| Hours | Location |
|
7:00 AM - 3:00 PM M-F |
One Joslin Pl Rm 476 |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Stephan Kissler, PhD |
Core Director
|
617-309-4071
|
Stephan.Kissler@joslin.harvard.edu
|
|
| Taylor Roberts |
Sr. Research Assistant
|
617-309-4072
|
Taylor.Roberts@joslin.harvard.edu
|
Lab 476
|
